Product Information
TRETINOIN 0.01% GEL is a generic product labeled by Padagis US LLC, priced at $2.7399 per GM under NDC 00574230115. Its NADAC has been published 473 times since Sep 13, 2017.
FDA first approved this application on Jun 11, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.1 mg/g
Manufacturer
Padagis US LLCNDC
00574230115
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
TRETINOINApproval Type
Generic (ANDA)
FDA Application
ANDA075589FDA Approved
6/11/2002
TE Code
AB
On Market Since
3/30/2017
Pharmacological Classes
Price Statistics
The NADAC for TRETINOIN 0.01% GEL has been published 473 times since Sep 13, 2017, and over the history we have for it it has declined 32.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7399 per GM |
|---|---|
| All-time high | $4.3416 (Oct 14, 2020) |
| All-time low | $2.1192 (Jul 17, 2024) |
| 52-week high | $3.5061 |
| 52-week low | $2.7399 |
| Median price | $3.5113 |
| Average price | $3.5549 |
| Largest weekly change | -31.0% (Nov 18, 2020) |
| Weeks tracked | 473 |
| Tracking since | Sep 13, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
tretinoin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Retinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRETINOIN 0.01% GEL?
The current National Average Drug Acquisition Cost (NADAC) for TRETINOIN 0.01% GEL, manufactured by Padagis US LLC, is $2.7399 per GM (NDC 00574230115), effective Sep 30, 2026.
How has the price of TRETINOIN 0.01% GEL changed over time?
Over the history we have for it, the NADAC for TRETINOIN 0.01% GEL has declined 32.9%. It has been tracked across 473 weekly CMS publications since Sep 13, 2017.
What are the highest and lowest recorded NADAC prices for TRETINOIN 0.01% GEL?
Since Sep 13, 2017, the NADAC for TRETINOIN 0.01% GEL has ranged from a low of $2.1192 (Jul 17, 2024) to a high of $4.3416 (Oct 14, 2020), with a median of $3.5113 per GM.
Are there cheaper alternatives to TRETINOIN 0.01% GEL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRETINOIN 0.01% GEL, is $2.3019 per GM — about 16% below TRETINOIN 0.01% GEL.
Who manufactures TRETINOIN 0.01% GEL?
TRETINOIN 0.01% GEL (NDC 00574230115) is labeled by Padagis US LLC, and CMS classifies it as a generic product.